Article Results (Showing 1 - 10 of 13) RSS Alert
-
Shire to Buy Out Partner
One equity analyst jokingly called it ransom - at a fair price. Shire P.L.C., the No. 1 maker of attention-deficit medications with U.S....
Philadelphia Inquirer, The, 02/21/07 by Thomas Ginsberg · More from publication -
Shire reaches deal to delay generic form of Adderall XR
Shire P.L.C., maker of the attention-deficit-hyperactivity-disorder medication Adderall XR, has held off a second rival company from marketing a...
Philadelphia Inquirer, The, 08/16/06 by Thomas Ginsberg · More from publication -
Shire settles pending litigation with Barr Laboratories
Shire PLC has settled all pending litigation with a company seeking to market a generic version of Shire's top-selling treatment for attention...
Philadelphia Inquirer, The, 08/15/06 by INQUIRER STAFF · More from publication -
Shire's earnings off 44%, partly from takeover cost
Shire P.L.C., the Britain-based pharmaceutical company with major operations in Wayne, said yesterday that profit fell 44 percent in the second...
Philadelphia Inquirer, The, 07/29/06 by Thomas Ginsberg · More from publication -
Marketing, acquisition costs drag down Shire’s profits
Shire P.L.C., the Britain-based pharmaceutical company with major operations in Wayne, said today that profit fell 44 percent in the second quarter...
Philadelphia Inquirer, The, 07/28/06 by Thomas Ginsberg · More from publication -
WALL STREET CHOICE: ADHD PATCH APPROVAL MEANS 'FAT' RATING FOR SHIRE
Annie Cheng, J.P. Morgan Stock: Shire Pharmaceuticals Rating: Overweight Price: $49.26 52-week range: $30.28-$50.30 The FDA approved Daytrana...
Medical Marketing and Media, 05/01/06 · More from publication -
Shire posted net loss of $410 million in fourth quarter
Shire P.L.C., maker of the world's No. 1 attention-deficit disorder drug, said today it posted a net loss of $410 million last year due to a spike...
Philadelphia Inquirer, The, 02/23/06 by Thomas Ginsberg · More from publication -
SHIRE PHARMA. (SHP).
Shire Pharmaceuticals has called on US regulators to carry out further investigations into the link between attention deficit hyperactivity...
Investors Chronicle, 02/17/06 · More from publication -
Adderall XR effective over long term
A once-daily dose of mixed amphetamine salts (Adderall XR) maintained improvement of ADHD symptoms in children aged 6-12 years during a 24-month...
Clinical Psychiatry News, 07/01/05 by Heidi Splete · More from publication -
[ STATE BRIEFS ]
Doctor, wife indicted over drugs KANSAS CITY, Kan. --- A Leawood doctor and his wife face federal charges of illegally distributing several...
Topeka Capital-Journal, The, 05/02/03 by Capital-Journal · More from publication
